Nathalie Dubois Stringfellow Sangamo Therapeutics, Inc (SGMO) insider trading activity

Nathalie Dubois Stringfellow is SVP-CHIEF DEVELOPMENT OFFICER of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 799,747 shares of SGMO, which is worth approximately $367,883. The most recent transaction as insider was on May 24, 2025, when has been sold 1,792 shares (Common Stock) at a price of $0.47 per share, resulting in proceeds of $842. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 800K

12.1% 3M change

5.12% 12M change

Total Value Held $367,883

Nathalie Dubois-Stringfellow Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 24 2025	SELL Payment of exercise price or tax liability	$842 $0.47 p/Share	1,792 Reduced 0.22%	799,747 Common Stock
Apr 22 2025	SELL Payment of exercise price or tax liability	$24,855 $0.78 p/Share	31,866 Reduced 3.82%	801,539 Common Stock
Feb 25 2025	SELL Payment of exercise price or tax liability	$1,452 $0.96 p/Share	1,513 Reduced 0.21%	713,405 Common Stock
Feb 25 2025	BUY Grant, award, or other acquisition	-	120,000 Added 12.59%	833,405 Common Stock
Feb 24 2025	SELL Payment of exercise price or tax liability	$1,792 $1.0 p/Share	1,792 Reduced 0.25%	714,918 Common Stock
Jan 22 2025	SELL Payment of exercise price or tax liability	$149,031 $1.15 p/Share	129,593 Reduced 15.31%	716,710 Common Stock
Nov 25 2024	SELL Payment of exercise price or tax liability	$2,925 $1.94 p/Share	1,508 Reduced 0.18%	841,303 Common Stock
Nov 24 2024	SELL Payment of exercise price or tax liability	$3,359 $1.88 p/Share	1,787 Reduced 0.21%	842,811 Common Stock
Aug 25 2024	SELL Payment of exercise price or tax liability	$1,296 $0.86 p/Share	1,508 Reduced 0.18%	844,598 Common Stock
Aug 24 2024	SELL Payment of exercise price or tax liability	$1,536 $0.86 p/Share	1,787 Reduced 0.21%	846,106 Common Stock
May 25 2024	SELL Payment of exercise price or tax liability	$904 $0.6 p/Share	1,508 Reduced 0.18%	842,893 Common Stock
May 24 2024	SELL Payment of exercise price or tax liability	$1,072 $0.6 p/Share	1,787 Reduced 0.21%	844,401 Common Stock
Feb 25 2024	SELL Payment of exercise price or tax liability	$5,661 $1.13 p/Share	5,010 Reduced 0.59%	846,188 Common Stock
Feb 24 2024	SELL Payment of exercise price or tax liability	$6,185 $1.13 p/Share	5,474 Reduced 0.64%	851,198 Common Stock
Jan 22 2024	BUY Grant, award, or other acquisition	-	712,500 Added 45.41%	856,672 Common Stock
Nov 25 2023	SELL Payment of exercise price or tax liability	$555 $0.38 p/Share	1,462 Reduced 1.04%	139,172 Common Stock
Aug 25 2023	SELL Payment of exercise price or tax liability	$1,125 $0.77 p/Share	1,462 Reduced 1.03%	140,634 Common Stock
May 25 2023	SELL Payment of exercise price or tax liability	$1,944 $1.33 p/Share	1,462 Reduced 1.06%	137,096 Common Stock
Feb 25 2023	SELL Payment of exercise price or tax liability	$26,158 $2.66 p/Share	9,834 Reduced 6.63%	138,558 Common Stock
Feb 24 2023	BUY Grant, award, or other acquisition	-	53,438 Added 26.48%	148,392 Common Stock

Nathalie Dubois Stringfellow

SVP-CHIEF DEVELOPMENT OFFICER

Brisbane, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Value

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO

Account